Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4037 Target Snapshot

Carnitine O-palmitoyltransferase 2, mitochondrial · SINGLE PROTEIN · Rattus norvegicus

480Compounds
10Assays
2Approved Drugs
479.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P18886. Use UniProt P18886 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P18886 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Carnitine O-palmitoyltransferase 2, mitochondrial as ChEMBL target CHEMBL4037, mapped to UniProt P18886. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Carnitine O-palmitoyltransferase 2, mitochondrial
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL4037
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P18886
Carnitine O-palmitoyltransferase 2, mitochondrial
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Carnitine O-palmitoyltransferase 2, mitochondrial is the right protein anchor across sources, using UniProt P18886 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCarnitine O-palmitoyltransferase 2, mitochondrial
UniProt AccessionP18886
Component TypeProtein
Sequence Length658 aa

Carnitine O-palmitoyltransferase 2, mitochondrial

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Carnitine O-palmitoyltransferase 2, mitochondrial, mapped to UniProt P18886. Sequence length is 658 aa.

Mapped IDP18886
Review nameCarnitine O-palmitoyltransferase 2, mitochondrial
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Approved
2
Phase II
Assay Mix

Activity Type Distribution

IC50474.0
KI5.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3431777 6.54 IC50 290.6 Preclinical
CHEMBL3431605 6.46 IC50 344.8 Preclinical
CHEMBL1231506 6.42 IC50 380.0 Clinical
CHEMBL3431737 6.32 IC50 477.3 Preclinical
CHEMBL3431735 6.3 IC50 495.6 Preclinical
CHEMBL3431736 6.27 IC50 538.8 Preclinical
CHEMBL3431801 6.19 IC50 642.6 Preclinical
CHEMBL3431602 6.17 IC50 684.3 Preclinical
CHEMBL3431739 6.15 IC50 701.2 Preclinical
CHEMBL2114397 6.1 IC50 800.0 Preclinical
Distribution

pChEMBL Value Distribution

32
5.0
26
5.5
12
6.0
1
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

10
Total Assays
179
Tested Compounds
1
Assay Types
Binding — 10 assays, 179 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 6 177 4.9
mitochondrion format 3 2 5.1
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine